{"transactions":[{"id":1440993,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-02","kind":"exercise","planned":true,"acquired":false,"shares":17857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has fully vested."}],"balance_after":1,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1440992,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":false,"shares":15476,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has fully vested."}],"balance_after":17858,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":15476},"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1440991,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-02","kind":"sale","planned":true,"acquired":false,"shares":17857,"price":4.361,"value":77874.377,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.235 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1440990,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-02","kind":"exercise","planned":true,"acquired":true,"shares":17857,"price":1.641,"value":29303.337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."}],"balance_after":42857,"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1440989,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":15476,"price":4.54,"value":70261.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.445 to $4.805, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1440988,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-08-05T18:57:07.000Z","date":"2024-08-01","kind":"exercise","planned":true,"acquired":true,"shares":15476,"price":1.641,"value":25396.116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."}],"balance_after":40476,"source":{"system":"sec-edgar","filing":"0001415889-24-020785","document":"form4-08052024_100803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924020785/form4-08052024_100803.xml","form_type":"4"}},{"id":1457006,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":false,"shares":13531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has fully vested."}],"balance_after":33334,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":13531},"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1457005,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-08","kind":"exercise","planned":true,"acquired":false,"shares":19802,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option has fully vested."}],"balance_after":46865,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":19802},"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1457004,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-09","kind":"sale","planned":true,"acquired":false,"shares":13531,"price":4.034,"value":54584.054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.105, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1457003,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-09","kind":"exercise","planned":true,"acquired":true,"shares":13531,"price":1.641,"value":22204.371,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."}],"balance_after":38531,"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1457002,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-08","kind":"sale","planned":true,"acquired":false,"shares":19802,"price":4.029,"value":79782.258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.055, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1457001,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-07-10T16:15:05.000Z","date":"2024-07-08","kind":"exercise","planned":true,"acquired":true,"shares":19802,"price":1.641,"value":32495.082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."}],"balance_after":44802,"source":{"system":"sec-edgar","filing":"0001415889-24-019463","document":"form4-07102024_040702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924019463/form4-07102024_040702.xml","form_type":"4"}},{"id":1470837,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-24T16:17:52.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option has fully vested."}],"balance_after":66667,"derivative":{"exercise_price":1.641,"expiration_date":"2030-01-20","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001415889-24-017956","document":"form4-06242024_080648.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924017956/form4-06242024_080648.xml","form_type":"4"}},{"id":1470836,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-06-24T16:17:52.000Z","date":"2024-06-20","kind":"sale","planned":true,"acquired":false,"shares":33333,"price":4.094,"value":136465.302,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.185, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-017956","document":"form4-06242024_080648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924017956/form4-06242024_080648.xml","form_type":"4"}},{"id":1470835,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES"}}],"security":"Common Stock","published_at":"2024-06-24T16:17:52.000Z","date":"2024-06-20","kind":"exercise","planned":true,"acquired":true,"shares":33333,"price":1.641,"value":54699.453,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024."}],"balance_after":58333,"source":{"system":"sec-edgar","filing":"0001415889-24-017956","document":"form4-06242024_080648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924017956/form4-06242024_080648.xml","form_type":"4"}},{"id":1569413,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES & MARKETING"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-19T18:21:40.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the shares underlying this option shall vest on March 15, 2025, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":4.31,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-008640","document":"form4-03192024_100327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924008640/form4-03192024_100327.xml","form_type":"4"}},{"id":1569412,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GLOBAL SALES & MARKETING"}}],"security":"Common Stock","published_at":"2024-03-19T18:21:40.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 15, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-24-008640","document":"form4-03192024_100327.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000141588924008640/form4-03192024_100327.xml","form_type":"4"}},{"id":1921153,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":false,"shares":5583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":13868,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":5583},"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921152,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-11","kind":"exercise","planned":true,"acquired":false,"shares":8451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":19451,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":8451},"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921151,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-10","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":27902,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921150,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-12","kind":"sale","planned":true,"acquired":false,"shares":5583,"price":5,"value":27915.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921149,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-12","kind":"exercise","planned":true,"acquired":true,"shares":5583,"price":2.142,"value":11958.786,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":5583,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921148,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-11","kind":"sale","planned":true,"acquired":false,"shares":8451,"price":5,"value":42255.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921147,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-11","kind":"exercise","planned":true,"acquired":true,"shares":8451,"price":2.142,"value":18102.042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":8451,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921146,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-10","kind":"sale","planned":true,"acquired":false,"shares":100,"price":5,"value":500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1921145,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-12T17:03:59.000Z","date":"2023-04-10","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":2.142,"value":214.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-23-024116","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123024116/doc4.xml","form_type":"4"}},{"id":1923090,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":false,"shares":27193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":28002,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":27193},"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1923089,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-05","kind":"exercise","planned":true,"acquired":false,"shares":6967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":55195,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":6967},"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1923088,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-06","kind":"sale","planned":true,"acquired":false,"shares":27193,"price":5.03,"value":136780.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1923087,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-06","kind":"exercise","planned":true,"acquired":true,"shares":27193,"price":2.142,"value":58247.406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":27193,"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1923086,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-05","kind":"sale","planned":true,"acquired":false,"shares":6967,"price":5,"value":34835.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1923085,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-07T16:43:27.000Z","date":"2023-04-05","kind":"exercise","planned":true,"acquired":true,"shares":6967,"price":2.142,"value":14923.314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":6967,"source":{"system":"sec-edgar","filing":"0001209191-23-023809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123023809/doc4.xml","form_type":"4"}},{"id":1928955,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-04","kind":"exercise","planned":true,"acquired":false,"shares":7266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":62162,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":7266},"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928954,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":69428,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928953,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-04T19:00:21.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":false,"shares":2607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":69528,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":2607},"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928952,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-04","kind":"sale","planned":true,"acquired":false,"shares":7266,"price":5.03,"value":36547.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928951,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-04","kind":"exercise","planned":true,"acquired":true,"shares":7266,"price":2.142,"value":15563.772,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":7266,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928950,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":5.01,"value":501.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928949,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-04-03","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":2.142,"value":214.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928948,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-03-31","kind":"sale","planned":true,"acquired":false,"shares":2607,"price":5,"value":13035.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1928947,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-04-04T19:00:21.000Z","date":"2023-03-31","kind":"exercise","planned":true,"acquired":true,"shares":2607,"price":2.142,"value":5584.194,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":2607,"source":{"system":"sec-edgar","filing":"0001209191-23-022988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123022988/doc4.xml","form_type":"4"}},{"id":1943286,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-21T16:42:51.000Z","date":"2023-03-20","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on March 20, 2024 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date."}],"balance_after":120000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-03-19","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-23-020287","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123020287/doc4.xml","form_type":"4"}},{"id":2033432,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":11575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":72135,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":11575},"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033431,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":15090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":83710,"derivative":{"exercise_price":2.142,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":15090},"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033430,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-01","kind":"exercise","acquired":false,"shares":2468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.983,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":2468},"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033429,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":11575,"price":5.77,"value":66787.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033428,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":11575,"price":2.142,"value":24793.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":11575,"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033427,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":17558,"price":5.68,"value":99729.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.51 to $5.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033426,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":15090,"price":2.142,"value":32322.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":17558,"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2033425,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-02-03T16:32:31.000Z","date":"2023-02-01","kind":"exercise","acquired":true,"shares":2468,"price":0.983,"value":2426.044,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":2468,"source":{"system":"sec-edgar","filing":"0001209191-23-006880","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123006880/doc4.xml","form_type":"4"}},{"id":2063143,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":9467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":2468,"derivative":{"exercise_price":0.983,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":9467},"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063142,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-04","kind":"exercise","acquired":false,"shares":9153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":11935,"derivative":{"exercise_price":0.983,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":9153},"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063141,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":10513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":21088,"derivative":{"exercise_price":0.983,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":10513},"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063140,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":9467,"price":5.04,"value":47713.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063139,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":9467,"price":0.983,"value":9306.061,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":9467,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063138,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-04","kind":"sale","acquired":false,"shares":9153,"price":5.07,"value":46405.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063137,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-04","kind":"exercise","acquired":true,"shares":9153,"price":0.983,"value":8997.399,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":9153,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063136,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":10513,"price":5.13,"value":53931.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.00 to $5.47, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2063135,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2023-01-05T17:31:00.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":10513,"price":0.983,"value":10334.279,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":10513,"source":{"system":"sec-edgar","filing":"0001209191-23-001980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919123001980/doc4.xml","form_type":"4"}},{"id":2094677,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":14133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":31601,"derivative":{"exercise_price":1.08,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":14133},"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2094676,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":45734,"derivative":{"exercise_price":1.08,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2094675,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":14133,"price":5.59,"value":79003.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.35 to $5.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2094674,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-05","kind":"exercise","acquired":true,"shares":14133,"price":1.08,"value":15263.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."}],"balance_after":14133,"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2094673,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":15000,"price":6.02,"value":90300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.00 to $6.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2094672,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-12-06T17:31:47.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":15000,"price":1.08,"value":16200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-22-060077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122060077/doc4.xml","form_type":"4"}},{"id":2125945,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-02","kind":"exercise","acquired":false,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":60734,"derivative":{"exercise_price":1.08,"expiration_date":"2026-06-13","underlying":"Common Stock","underlying_shares":1266},"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125944,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-02","kind":"exercise","acquired":false,"shares":4438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":4438},"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125943,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-01","kind":"exercise","acquired":false,"shares":23429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable."}],"balance_after":4438,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":23429},"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125942,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":5704,"price":6.85,"value":39072.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.72 to $6.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125941,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-02","kind":"exercise","acquired":true,"shares":1266,"price":1.08,"value":1367.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant."}],"balance_after":5704,"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125940,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-02","kind":"exercise","acquired":true,"shares":4438,"price":0.84,"value":3727.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":4438,"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125939,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-01","kind":"sale","acquired":false,"shares":23429,"price":6.94,"value":162597.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.80 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2125938,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-11-03T16:53:00.000Z","date":"2022-11-01","kind":"exercise","acquired":true,"shares":23429,"price":0.84,"value":19680.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":23429,"source":{"system":"sec-edgar","filing":"0001209191-22-055528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122055528/doc4.xml","form_type":"4"}},{"id":2138451,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-11","kind":"exercise","acquired":false,"shares":4282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":27867,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":4282},"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2138450,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-10","kind":"exercise","acquired":false,"shares":24851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":32149,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":24851},"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2138449,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":4282,"price":6.51,"value":27875.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.40 to $6.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2138448,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-11","kind":"exercise","acquired":true,"shares":4282,"price":0.84,"value":3596.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":4282,"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2138447,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-10","kind":"sale","acquired":false,"shares":24851,"price":6.45,"value":160288.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.31 to $6.64, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2138446,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Common Stock","published_at":"2022-10-12T16:09:48.000Z","date":"2022-10-10","kind":"exercise","acquired":true,"shares":24851,"price":0.84,"value":20874.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022."}],"balance_after":24851,"source":{"system":"sec-edgar","filing":"0001209191-22-053456","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122053456/doc4.xml","form_type":"4"}},{"id":2315532,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales & Marketing"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-29T16:20:00.000Z","date":"2022-03-25","kind":"grant","acquired":true,"shares":142000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on March 25, 2023 and the remaining 75% vest in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the Issuer at each vesting date."}],"balance_after":142000,"derivative":{"exercise_price":7.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":142000},"source":{"system":"sec-edgar","filing":"0001209191-22-021474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919122021474/doc4.xml","form_type":"4"}},{"id":2511125,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-16","kind":"exercise","acquired":false,"shares":31163,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":57000,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":31163},"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511124,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-15","kind":"exercise","acquired":false,"shares":51352,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":88163,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":51352},"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511123,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-12","kind":"exercise","acquired":false,"shares":42590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable."}],"balance_after":139515,"derivative":{"exercise_price":0.84,"expiration_date":"2026-01-10","underlying":"Common Stock","underlying_shares":42590},"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511122,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":31163,"price":12.08,"value":376449.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511121,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-16","kind":"exercise","acquired":true,"shares":31163,"price":0.84,"value":26176.92,"ownership":{"direct":true},"balance_after":31163,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511120,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":51352,"price":12.16,"value":624440.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511119,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-15","kind":"exercise","acquired":true,"shares":51352,"price":0.84,"value":43135.68,"ownership":{"direct":true},"balance_after":51352,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511118,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-12","kind":"sale","acquired":false,"shares":42590,"price":12.66,"value":539189.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2511117,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Common Stock","published_at":"2021-11-16T19:10:49.000Z","date":"2021-11-12","kind":"exercise","acquired":true,"shares":42590,"price":0.84,"value":35775.6,"ownership":{"direct":true},"balance_after":42590,"source":{"system":"sec-edgar","filing":"0001209191-21-064881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121064881/doc4.xml","form_type":"4"}},{"id":2607159,"issuer":{"id":6608,"kind":"organization","name":"MAXCYTE, INC."},"owners":[{"id":88504,"kind":"person","name":"Ross Thomas M.","position":1,"cik":"0001874572","reported_name":"Ross Thomas M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Global Sales"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-11T17:19:06.000Z","date":"2021-08-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying the option vest on August 9, 2022 and the remaining shares underlying the option vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":16.63,"expiration_date":"2031-08-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1874572/000120919121050949/doc4.xml","form_type":"4"}}]}